INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 155 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,950,558 | +39.9% | 75,841 | +70.1% | 0.10% | +33.8% |
| Q2 2023 | $2,823,186 | +58.5% | 44,586 | +35.5% | 0.07% | +51.0% |
| Q1 2023 | $1,781,156 | +2.9% | 32,893 | +0.5% | 0.05% | 0.0% |
| Q4 2022 | $1,731,754 | +263.1% | 32,724 | +291.4% | 0.05% | +133.3% |
| Q2 2022 | $477,000 | -23.9% | 8,360 | -45.6% | 0.02% | -60.4% |
| Q2 2021 | $627,000 | +2.0% | 15,366 | -61.6% | 0.05% | +17.8% |
| Q1 2020 | $615,000 | +348.9% | 39,986 | +117.5% | 0.04% | +275.0% |
| Q3 2019 | $137,000 | -45.0% | 18,383 | +30.4% | 0.01% | -29.4% |
| Q2 2018 | $249,000 | -33.4% | 14,096 | -20.7% | 0.02% | -34.6% |
| Q1 2018 | $374,000 | -30.6% | 17,780 | -52.2% | 0.03% | -55.9% |
| Q4 2017 | $539,000 | +6.1% | 37,203 | +15.6% | 0.06% | -53.9% |
| Q3 2017 | $508,000 | +32.3% | 32,176 | +36.0% | 0.13% | +161.2% |
| Q1 2017 | $384,000 | +15.3% | 23,652 | +175.6% | 0.05% | +11.4% |
| Q2 2016 | $333,000 | -50.8% | 8,581 | -59.5% | 0.04% | -42.1% |
| Q2 2015 | $677,000 | – | 21,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |